On ECHEMI
Home > Drugs > China Resources Double-Crane Pharmaceutical Co., Ltd.
China Resources Double-Crane Pharmaceutical Co., Ltd.
  • Founded in:

    1997-05-16
  • Country:

    China China
  • Address:

    No. 1, Lize East 2nd Road, Wangjing, Chaoyang District, Beijing
  • Tax NO.:

    91110000633796475U
  • Registered Funds:

    1,038,836,522 yuan
  • Website:

  • Email:

Related Drugs
Sodium ferulate tablets
Sodium ferulate. Chemical name: 3-methoxy-4-hydroxycinnamic acid sodium salt dihydrate.
Name Description Content CAS NO. Registered Holders
Sodium ferulic

Non-peptide endothelin receptor antagonists can antagonize endothelin-induced vasoconstriction, blood pressure increase, and vascular smooth muscle cell proliferation; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. They can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent and treat lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects.

More

Non-peptide endothelin receptor antagonists can antagonize endothelin-induced vasoconstriction, blood pressure increase, and vascular smooth muscle cell proliferation; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. They can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent and treat lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects.

24276-84-4 8
Nefopam Hydrochloride Tablets
The main component of this product and its chemical name is: 5-methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-oxazolidinone hydrochloride. Its structural formula is: Molecular formula: C17H19NO·HCl Molecular weight: 289.80
Name Description Content CAS NO. Registered Holders
Nefopam hydrochloride

This product is a new type of non-narcotic analgesic, with mild antipyretic and muscle relaxant effects. Its chemical structure belongs to cyclized o-methylbenzylamine. Therefore, it does not have the characteristics of non-steroidal anti-inflammatory drugs, nor is it an opioid receptor agonist. It is effective for moderate and severe pain. An intramuscular injection of 20 mg of this product is equivalent to the effect of 12 mg of morphine. It has a mild respiratory depressant effect. It has no depressant effect on the circulatory system. There is no tolerance and dependence.

More

This product is a new type of non-narcotic analgesic, with mild antipyretic and muscle relaxant effects. Its chemical structure belongs to cyclized o-methylbenzylamine. Therefore, it does not have the characteristics of non-steroidal anti-inflammatory drugs, nor is it an opioid receptor agonist. It is effective for moderate and severe pain. An intramuscular injection of 20 mg of this product is equivalent to the effect of 12 mg of morphine. It has a mild respiratory depressant effect. It has no depressant effect on the circulatory system. There is no tolerance and dependence.

23327-57-3 12
Fenbufen Tablets
The main ingredient of this product is fenbufen (C16H14O3), whose chemical name is 3-(4-biphenylcarbonyl) propionic acid. Its structural formula is: Molecular formula: C16H14O3 Molecular weight: 254.28
Name Description Content CAS NO. Registered Holders
Fenbufen

This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin.

More

This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin.

36330-85-5 8
Cloperidin Hydrochloride Tablets
The content of cloperidine hydrochloride (C20H24ClNOHCl) in this product should be 90.0-110.0% of the labeled amount.
Name Description Content CAS NO. Registered Holders
Cloperastine hydrochloride

This product is an analogue of diphenhydramine, which mainly suppresses cough center and relieves cough. It also has a weak antihistamine effect and has no dependence or tolerance. It takes effect 20-30 minutes after taking it and the effect lasts for 3-4 hours.

More

This product is an analogue of diphenhydramine, which mainly suppresses cough center and relieves cough. It also has a weak antihistamine effect and has no dependence or tolerance. It takes effect 20-30 minutes after taking it and the effect lasts for 3-4 hours.

90.0~110.0%Label quantity 14984-68-0 6
Nicorandil Tablets
The main ingredient of this product is Nicorandil, and its chemical name is: nicotinamide ethyl nitrate.
Name Description Content CAS NO. Registered Holders
Nicorandil

Anti-angina drug. This product belongs to the nitrate compound, which has the effect of preventing the free calcium ions in cells, increasing the permeability of cell membranes to potassium ions, dilating coronary blood vessels, continuously increasing coronary blood flow, and inhibiting coronary artery spasm. When dilating coronary blood vessels, it does not affect blood pressure, heart rate, myocardial contractility, and myocardial oxygen consumption. This product also has the effect of inhibiting platelet aggregation and preventing thrombosis.

More

Anti-angina drug. This product belongs to the nitrate compound, which has the effect of preventing the free calcium ions in cells, increasing the permeability of cell membranes to potassium ions, dilating coronary blood vessels, continuously increasing coronary blood flow, and inhibiting coronary artery spasm. When dilating coronary blood vessels, it does not affect blood pressure, heart rate, myocardial contractility, and myocardial oxygen consumption. This product also has the effect of inhibiting platelet aggregation and preventing thrombosis.

65141-46-0 33
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.